Abu Dhabi Growth Fund: Orbital Therapeutics Raises $270M in Series A Financing

Orbital Therapeutics, a Cambridge, MA-based company focused on developing RNA-based medicines to treat human diseases, raised $270M in Series A funding. The round was led by ARCH Venture Partners, with participation from initial investors a16z Bio + Health and Newpath Partners, and new investors Abu Dhabi Growth Fund (ADG), Redmile Group, Exor N.V., Invus, Moore [...]The post Orbital Therapeutics Raises $270M in Series A Financing appeared first on FinSMEs.